دورية أكاديمية
Comprehensive Analysis of NKX3.2 in Liver Hepatocellular Carcinoma by Bigdata
العنوان: | Comprehensive Analysis of NKX3.2 in Liver Hepatocellular Carcinoma by Bigdata |
---|---|
المؤلفون: | An-Na Bae, Jongwan Kim, Jong-Ho Park, Jae-Ho Lee, Euncheol Choi |
المصدر: | Medicina, Vol 59, Iss 10, p 1782 (2023) |
بيانات النشر: | MDPI AG, 2023. |
سنة النشر: | 2023 |
المجموعة: | LCC:Medicine (General) |
مصطلحات موضوعية: | NKX3.2, liver hepatocellular carcinoma, TIMER, GEPIA2, Medicine (General), R5-920 |
الوصف: | Background and Objectives: The gene NKX3.2 plays a role in determining cell fate during development, and mutations of NKX3.2 have been studied in relation to human skeletal diseases. However, due to the lack of studies on the link between NKX3.2 and cancer, we aimed to provide insights into NKX3.2 as a new prognostic biomarker for liver hepatocellular carcinoma (LIHC). Materials and Methods: The clinical significance of LIHC was investigated using open gene expression databases. We comprehensively analyzed NKX3.2 expression in LIHC using Gene Expression Profiling Interactive Analysis 2, Tumor Immune Estimation Resource (TIMER), and Kaplan–Meier plotter databases. Then, we investigated the association between NKX3.2 expression and tumor-infiltrating immune cells (TIICs). Results: NKX3.2 expression was higher in the primary tumor group compared to the normal group, and expression was higher in fibrolamellar carcinoma (FLC) compared to other subtypes. When the prognostic value of NKX3.2 was evaluated, highly expressed NKX3.2 significantly improved the overall survival and had an unfavorable prognosis. In addition, NKX3.2 expression was associated with immune cell infiltration. Patients with low gene expression and high macrophage expression had a poorer survival rate than those with low NKX3.2 and low macrophage expression (p = 0.0309). Conclusions: High NKX3.2 expression may induce poorer prognosis in LIHC. In addition, these findings can be used as basic data due to the lack of available related research. However, further in vivo studies are essential to gain a deeper understanding of the biological role of NKX3.2 in LIHC and its potential implications for cancer development and progression. |
نوع الوثيقة: | article |
وصف الملف: | electronic resource |
اللغة: | English |
تدمد: | 1648-9144 1010-660X |
Relation: | https://www.mdpi.com/1648-9144/59/10/1782; https://doaj.org/toc/1010-660X; https://doaj.org/toc/1648-9144 |
DOI: | 10.3390/medicina59101782 |
URL الوصول: | https://doaj.org/article/db9425551f30432d8884add8caa88a36 |
رقم الأكسشن: | edsdoj.b9425551f30432d8884add8caa88a36 |
قاعدة البيانات: | Directory of Open Access Journals |
تدمد: | 16489144 1010660X |
---|---|
DOI: | 10.3390/medicina59101782 |